Flputnam Investment Management CO Abbott Laboratories Transaction History

Flputnam Investment Management CO

  • $5.29 Billion
  • Q2 2024

A detailed history of Flputnam Investment Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Flputnam Investment Management CO holds 133,312 shares of ABT stock, worth $15 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
133,312
Previous 112,505 18.49%
Holding current value
$15 Million
Previous $12.8 Million 8.33%
% of portfolio
0.26%
Previous 0.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$100.73 - $112.44 $2.1 Million - $2.34 Million
20,807 Added 18.49%
133,312 $13.9 Million
Q1 2024

May 03, 2024
SELL
$109.52 - $120.96 $610,354 - $674,110
-5,573 Reduced 4.72%
112,505 $12.8 Million
Q4 2023

Jan 30, 2024
SELL
$90.19 - $110.4 $600,034 - $734,491
-6,653 Reduced 5.33%
118,078 $13 Million
Q3 2023

Nov 06, 2023
BUY
$95.53 - $114.62 $510,894 - $612,987
5,348 Added 4.48%
124,731 $12.1 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $4.98 Million - $5.55 Million
49,431 Added 70.66%
119,383 $13 Million
Q1 2023

Apr 27, 2023
BUY
$96.86 - $114.01 $623,294 - $733,654
6,435 Added 10.13%
69,952 $7.08 Million
Q4 2022

Jan 31, 2023
SELL
$95.06 - $111.52 $5.69 Million - $6.67 Million
-59,843 Reduced 48.51%
63,517 $6.97 Million
Q3 2022

Nov 07, 2022
SELL
$96.76 - $112.03 $5.7 Million - $6.6 Million
-58,917 Reduced 32.32%
123,360 $11.9 Million
Q2 2022

Aug 08, 2022
SELL
$102.07 - $123.37 $371,943 - $449,560
-3,644 Reduced 1.96%
182,277 $19.8 Million
Q1 2022

Apr 28, 2022
BUY
$114.02 - $139.04 $748,199 - $912,380
6,562 Added 3.66%
185,921 $22 Million
Q4 2021

Feb 15, 2022
BUY
$115.53 - $141.46 $2.04 Million - $2.5 Million
17,647 Added 10.91%
179,359 $25.2 Million
Q3 2021

Oct 26, 2021
BUY
$116.66 - $129.06 $584,466 - $646,590
5,010 Added 3.2%
161,712 $19.1 Million
Q2 2021

Aug 11, 2021
BUY
$105.79 - $124.53 $645,636 - $760,006
6,103 Added 4.05%
156,702 $18.2 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $3.28 Million - $3.86 Million
-30,104 Reduced 16.66%
150,599 $18 Million
Q4 2020

Feb 02, 2021
SELL
$105.0 - $114.42 $233,520 - $254,470
-2,224 Reduced 1.22%
180,703 $19.8 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $2.54 Million - $3.08 Million
-27,695 Reduced 13.15%
182,927 $19.9 Million
Q2 2020

Aug 13, 2020
BUY
$76.57 - $98.0 $6,431 - $8,232
84 Added 0.04%
210,622 $19.3 Million
Q1 2020

May 08, 2020
SELL
$62.82 - $91.86 $109,620 - $160,295
-1,745 Reduced 0.82%
210,538 $16.6 Million
Q4 2019

Jan 30, 2020
BUY
$78.51 - $87.4 $4.15 Million - $4.62 Million
52,917 Added 33.2%
212,283 $18.4 Million
Q3 2019

Nov 05, 2019
BUY
$81.84 - $88.74 $584,337 - $633,603
7,140 Added 4.69%
159,366 $13.3 Million
Q2 2019

Jul 25, 2019
SELL
$72.88 - $85.0 $413,594 - $482,375
-5,675 Reduced 3.59%
152,226 $12.8 Million
Q1 2019

May 15, 2019
BUY
$66.22 - $80.06 $121,248 - $146,589
1,831 Added 1.17%
157,901 $12.6 Million
Q4 2018

Feb 22, 2019
BUY
$65.56 - $74.27 $30,944 - $35,055
472 Added 0.3%
156,070 $11.3 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $1.79 Million - $2.16 Million
29,452 Added 23.35%
155,598 $11.4 Million
Q2 2018

Aug 01, 2018
BUY
$57.57 - $63.54 $1.35 Million - $1.49 Million
23,504 Added 22.9%
126,146 $7.69 Million
Q1 2018

May 01, 2018
SELL
$56.27 - $63.62 $461,188 - $521,429
-8,196 Reduced 7.39%
102,642 $6.15 Million
Q4 2017

Feb 06, 2018
BUY
$53.68 - $57.47 $90,450 - $96,836
1,685 Added 1.54%
110,838 $6.33 Million
Q3 2017

Nov 07, 2017
BUY
$48.06 - $53.64 $5.25 Million - $5.85 Million
109,153
109,153 $5.82 Million

Others Institutions Holding ABT

# of Institutions
3,138
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email